News
BlueBird Bio Shares Soar 53.30% After FDA’s Committee Approves its Beti-cel Gene Therapy
Bluebird Bio Stock surges nearly 53% after an advisory committee to the U.S. Food and Drug Administration votes to approve beti-cel gene therapy ...
